145 related articles for article (PubMed ID: 26448128)
1. Synthesis of Monodisperse Chitosan Nanoparticles and in Situ Drug Loading Using Active Microreactor.
Kamat V; Marathe I; Ghormade V; Bodas D; Paknikar K
ACS Appl Mater Interfaces; 2015 Oct; 7(41):22839-47. PubMed ID: 26448128
[TBL] [Abstract][Full Text] [Related]
2. Amphotericin-B entrapped lecithin/chitosan nanoparticles for prolonged ocular application.
Chhonker YS; Prasad YD; Chandasana H; Vishvkarma A; Mitra K; Shukla PK; Bhatta RS
Int J Biol Macromol; 2015 Jan; 72():1451-8. PubMed ID: 25453292
[TBL] [Abstract][Full Text] [Related]
3. Chitosan functionalized poly (ε-caprolactone) nanoparticles for amphotericin B delivery.
Vásquez Marcano RGDJ; Tominaga TT; Khalil NM; Pedroso LS; Mainardes RM
Carbohydr Polym; 2018 Dec; 202():345-354. PubMed ID: 30287009
[TBL] [Abstract][Full Text] [Related]
4. Optimization of physicochemical parameters influencing the fabrication of protein-loaded chitosan nanoparticles.
Vandana M; Sahoo SK
Nanomedicine (Lond); 2009 Oct; 4(7):773-85. PubMed ID: 19839813
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of chitosan based nanoparticles and their in vitro evaluation against phytopathogenic fungi.
Saharan V; Mehrotra A; Khatik R; Rawal P; Sharma SS; Pal A
Int J Biol Macromol; 2013 Nov; 62():677-83. PubMed ID: 24141067
[TBL] [Abstract][Full Text] [Related]
6. Self-aggregated nanoparticles based on amphiphilic poly(lactic acid)-grafted-chitosan copolymer for ocular delivery of amphotericin B.
Zhou W; Wang Y; Jian J; Song S
Int J Nanomedicine; 2013; 8():3715-28. PubMed ID: 24106427
[TBL] [Abstract][Full Text] [Related]
7. Chitosan based micro- and nanoparticles for colon-targeted delivery of vancomycin prepared by alternative processing methods.
Cerchiara T; Abruzzo A; di Cagno M; Bigucci F; Bauer-Brandl A; Parolin C; Vitali B; Gallucci MC; Luppi B
Eur J Pharm Biopharm; 2015 May; 92():112-9. PubMed ID: 25769679
[TBL] [Abstract][Full Text] [Related]
8. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
Gan Q; Wang T; Cochrane C; McCarron P
Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):65-73. PubMed ID: 16024239
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of letrozole formulation using chitosan nanoparticles through ionic gelation method.
Gomathi T; Sudha PN; Florence JAK; Venkatesan J; Anil S
Int J Biol Macromol; 2017 Nov; 104(Pt B):1820-1832. PubMed ID: 28185930
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells.
Kumar SP; Birundha K; Kaveri K; Devi KT
Int J Biol Macromol; 2015; 78():87-95. PubMed ID: 25840152
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization and in vitro release study of carvacrol-loaded chitosan nanoparticles.
Keawchaoon L; Yoksan R
Colloids Surf B Biointerfaces; 2011 May; 84(1):163-71. PubMed ID: 21296562
[TBL] [Abstract][Full Text] [Related]
12. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique.
Fan W; Yan W; Xu Z; Ni H
Colloids Surf B Biointerfaces; 2012 Feb; 90():21-7. PubMed ID: 22014934
[TBL] [Abstract][Full Text] [Related]
13. Facile preparation of well-defined near-monodisperse chitosan/sodium alginate polyelectrolyte complex nanoparticles (CS/SAL NPs) via ionotropic gelification: a suitable technique for drug delivery systems.
Liu P; Zhao X
Biotechnol J; 2013 Jul; 8(7):847-54. PubMed ID: 23625874
[TBL] [Abstract][Full Text] [Related]
14. Preparation of polyelectrolyte complex nanoparticles of chitosan and poly(2-acry1amido-2-methylpropanesulfonic acid) for doxorubicin release.
Zhang L; Wang J; Ni C; Zhang Y; Shi G
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():724-9. PubMed ID: 26478364
[TBL] [Abstract][Full Text] [Related]
15. Controlled release of an endostatin peptide using chitosan nanoparticles.
Ebrahimi Samani S; Seraj Z; Naderimanesh H; Khajeh K; Esmaeili Rastaghi AR; Droudi T; Kolivand P; Kazemi H; Asghari SM
Chem Biol Drug Des; 2017 Sep; 90(3):417-424. PubMed ID: 28165672
[TBL] [Abstract][Full Text] [Related]
16. Preparation and optimization of chitosan nanoparticles and magnetic chitosan nanoparticles as delivery systems using Box-Behnken statistical design.
Elmizadeh H; Khanmohammadi M; Ghasemi K; Hassanzadeh G; Nassiri-Asl M; Garmarudi AB
J Pharm Biomed Anal; 2013 Jun; 80():141-6. PubMed ID: 23571126
[TBL] [Abstract][Full Text] [Related]
17. Controlled release and enhanced biological activity of chitosan-fabricated carbenoxolone nanoparticles.
Bharathala S; Singh R; Sharma P
Int J Biol Macromol; 2020 Dec; 164():45-52. PubMed ID: 32679335
[TBL] [Abstract][Full Text] [Related]
18. Preparation, optimization, and in-vitro/in-vivo/ex-vivo characterization of chitosan-heparin nanoparticles: drug-induced gelation.
Shahbazi MA; Hamidi M; Mohammadi-Samani S
J Pharm Pharmacol; 2013 Aug; 65(8):1118-33. PubMed ID: 23837580
[TBL] [Abstract][Full Text] [Related]
19. Monodisperse chitosan nanoparticles for mucosal drug delivery.
Zhang H; Oh M; Allen C; Kumacheva E
Biomacromolecules; 2004; 5(6):2461-8. PubMed ID: 15530064
[TBL] [Abstract][Full Text] [Related]
20. Development of new chitosan/carrageenan nanoparticles for drug delivery applications.
Grenha A; Gomes ME; Rodrigues M; Santo VE; Mano JF; Neves NM; Reis RL
J Biomed Mater Res A; 2010 Mar; 92(4):1265-72. PubMed ID: 19322874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
